Protein levels of CAB39 and phosphorylated AMPK were higher, and levels of phosphorylated mTOR were lower in miR-107 inhibitor-treated cells than the control group in CRC cells (Fig. 4h and Supplementary Fig. 2D). This evidence concerns the gene MTOR and colorectal carcinoma.